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The genetic basis of  
craniofacial and dental  
abnormalities
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Introduction
Disturbances in normal head development during embryogen-
esis manifest clinically as malformations that affect orofacial 
and dental structures.
For example, abnormalities in the growth or fusion of the 
facial processes may result either in orofacial clefts or severe 
disorders such as holoprosencephaly, where the midline of the 
face “collapses”. Similarly, tooth abnormalities are usually the 
result of disturbances in the “molecular dialogue” between the 
oral epithelium and the underlying mesenchyme during tooth 
development, which can result in tooth agenesis of varying 
severity with failure to form the correct number of teeth.
Much of our knowledge on the role of specific genes in the 
formation of the human head has originated from studying 
the genome of family members with a particular orofacial or 
dental disorder. In the past 30 years the discovery and avail-
ability of genetic markers across the human genome has al-
lowed the analysis of the genetic code responsible for these 
disorders. In addition, the techniques of cloning and sequenc-
ing greatly contributed in the identification of specific genes 
that are responsible for these defects.
Furthermore, animal models, and most particularly mouse 
models, have become invaluable tools for understanding the 
molecular processes that govern head development. The ge-
netic programs controlling head development appear to be 
highly conserved between all vertebrates. Together with the 
sequencing of the mouse and human genomes, of particular 
help is the technology of gene “knock-out” (deletion/inactiva-
tion), by which a specific gene believed to be involved in a 
human orofacial or dental disorder can be inactivated in the 
mouse, offering valuable information about malformations 
observed in humans. The detailed study of the resulting phe-
notypes constitutes the starting point for the elucidation of 
the molecular pathways involved in these abnormalities.
In this review, we discuss some of the cellular and molecular 
processes involved in the development of the orofacial com-
plex and teeth. We focus on the results obtained from studies 
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mesodermal cell population. Further specification and organ-
isation of the CNC cells into distinct elements (such as bones 
and teeth) takes place by means of a continuous “molecular 
dialogue” with the epithelium that covers the developing face 
and oral cavity. In this molecular “dialogue” the interaction 
between CNC cells and epithelium involves proteins that are 
products of specific genes. These proteins instruct cells to ei-
ther divide or die (apoptosis), migrate/proliferate or differenti-
ate into more specific cell types such as osteoblasts, odonto-
blasts, chondrocytes, etc.
Orofacial and dental disorders result when mutations in the 
sequence of either a gene or a group of genes cause alterations 
to the expression or function of the encoded protein(s). Gene 
mutations, but also environmental factors, can affect the ex-
pression of genes or interfere with the normal function of their 
protein products.
Growth and transcription factors
The fate of cells is regulated by signalling molecules. These are 
chemical substances (hormones, neurotransmitters, etc.) syn-
thesized and secreted by cells for the purpose of extracellular 
communication with other cells. Upon binding to their respec-
tive cell-surface receptors these signalling molecules initiate a 
chain of molecular events and activate specific transcription 
factors (proteins that bind directly to DNA). These transcrip-
tion factors bind to regulatory regions of the genome and di-
rect the expression or repression of specific sets of genes that 
control cell behaviour (Fig. 2).
The above process is a crucial and repeated event in the de-
veloping embryo and the basis for the correct formation of all 
in humans and mouse models that have helped to identify the 
genetic causes of specific abnormalities with emphasis on the 
subjects of oral clefts and tooth agenesis (oligodontia/hypodon-
tia/anodontia).
Finally, we present the clinical benefits that could derive 
from the development of new technologies combined with our 
knowledge on the genetic manifestations of craniofacial and 
dental defects.
Head formation
The formation of the head occurs at the earliest stages of hu-
man embryonic development (Wilkie & Morris-Kay 2001). This 
process is very complex and under a tight genetic control.
For the development of the head a group of cells with stem 
cell properties, called cranial neural crest (CNC) cells, are of 
particular importance. These cells delaminate from the lateral 
ridges of the neural plate (which will form the neural tube) 
and then emigrate towards the developing branchial arches. 
Subgroups of cranial neural crest cells migrate towards specific 
areas where they intermingle with the existing population of 
mesodermal cells (Fig. 1). The proliferation of the CNC cells is 
responsible for the budding of tissues around the future oral 
cavity. Continuous neural crest stem cell proliferation leads to 
the formation of a single frontonasal process and of pairs of 
maxillary and mandibular processes (Fig. 1). As development 
advances, all these processes join and fuse giving rise to the 
completed face. Thereafter, in both the maxillary and man-
dibular processes teeth will form. 
The CNC cells will give rise to virtually all head structures 
with the exception of the muscles, which are formed by a 
                Lateral view        Frontal view
Fig. 1 Migration of neural crest cells and formation of facial prominences
Different groups of neural crest cells (coloured arrows and dots) are somehow instructed to follow each a specific migration path and reach a specific final 
 destination. There, the neural crest cells proliferate and the facial prominences form.
Key: fnp, frontonasal prominence; lnp, lateral nasal prominence; mxp, maxillary prominence; mdp, mandibular prominence; r, rhombomere.
The frontal view is a redrawn figure from the book “Human Embryology and Developmental Biology” by Bruce M Carlson, 2004.
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transgenic mice indicated that members of the FGF family are 
likely to be involved in tooth root formation and elongation 
(Ota et al. 2007).
However, there is no direct indication from genetic mapping 
studies for a role of FGFs in the common forms of hypodontia 
(Arte et al. 2001). Mutations in the growth factor FGF23 in 
humans cause an abnormality called Autosomal Dominant 
Hypophosphataemic Rickets (ADHR) (White et al. 2000). The 
clinical presentation of this condition includes teeth with hy-
pomineralized dentine, enlarged pulp chambers and non-cari-
ous exposure of the pulp leading to dental abscesses (Pereira et 
al. 2004).
The Hedgehog signalling pathway
Sonic hedgehog (SHH) is the main member of the Hedgehog 
family which is associated with abnormal orofacial and tooth 
development.
SHH is expressed in the ectoderm of the frontonasal and 
maxillary processes during development. In humans, muta-
tions of SHH result in holoprosencephaly, demonstrating the 
crucial role of this growth factor in the development of the 
face (Roessler et al. 1996). In the chick model, the transient 
loss of SHH signalling results in midfacial clefts analogous to 
the human cleft lip/palate. In contrast, excessive SHH expres-
sion leads to midfacial widening with increased space between 
the eyes similar to the human condition hypertelorism (Hu & 
Helms 1999).
SHH is also expressed at all stages of tooth development and 
has been shown to be important for the initiation of tooth 
formation (Hardcastle et al. 1998), crown morphology and 
tooth size (Dassule et al. 2000). Furthermore, SHH is impor-
tant for the proliferation of the dental epithelial cells and 
their final differentiation into ameloblasts (Gritli-Linde et al. 
2002, Takahashi et al. 2007). Mice with a defect on the SHH 
receptor exhibit delayed root development and tooth eruption 
(Nakatomi et al. 2006).
Similarly, transgenic mice that overexpress the SHH protein 
in epithelia exhibit phenotypes of cleft palate and arrested 
tooth formation (Cobourne et al. 2009).
In humans, the Gorlin-Goltz (nevoid basal cell carcinoma) 
syndrome is associated with hypodontia and clefts. This syn-
drome could be in certain cases caused by mutations in a gene 
showing high homology to a Drosophila SHH receptor (Hahn 
et al. 1996).
embryonic structures including the head. Studies on orofacial 
and tooth development have identified a number of key signal-
ling molecules (mainly growth factors) and transcription factors.
Growth factors are peptide or steroid hormone molecules 
which stimulate cellular growth, proliferation and differentia-
tion. The growth factors involved in orofacial development 
belong mainly to four families that are well conserved between 
different species: the Fibroblast Growth Factor (FGF) family, 
the Hedgehog (HH) family, the Wingless (WNT) family and the 
Transforming Growth Factor beta (TGF-) family, which in-
cludes the Bone Morphogenetic Proteins (BMPs) and Activins.
Mutations in genes of these signalling pathways or environ-
mental factors that interfere with the growth factors often 
affect the developing organism in a predictable manner. For 
this reason the resulting phenotypic changes are often com-
parable between humans and other vertebrates such as the 
mouse.
The FGF signalling pathway
The FGF family of growth factors consists of 25 members. 
There are four major FGF receptors, but multiple variants exist 
and split the four main receptors into a total of seven key hu-
man FGF receptors: FGFR1b, FGFR1c, FGFR2b, FGFR2c, FGFR3b, 
FGFR3c, and FGFR4. Each receptor can be activated by specific 
members of the FGF family.
The FGF signalling pathway is active in both the facial epi-
thelium and mesenchyme and is mainly involved in stimulat-
ing cell proliferation. Mutations in FGF molecules or their re-
ceptors can result in craniosynostosis (Kim et al. 1998, Johnson 
et al. 2000), which reflects the role of FGF signalling in the 
processes of osteogenesis and chondrogenesis.
During palatal formation, FGF molecules and their receptors 
are expressed in the developing palatal shelves (Lee et al. 2001). 
In humans, mutations which essentially inactivate the FGFR1 
cause Kallmann syndrome. A small percentage of patients with 
this syndrome present with cleft lip (Dode et al. 2003, Kim et 
al. 2005). Transgenic mice carrying a deletion of the gene en-
coding for either the FGF10 factor or the FGFR2b exhibit a cleft 
palate phenotype (Rice et al. 2004). Interestingly, cleft palate 
is a frequent feature of many patients (44%) presenting with 
craniosynostosis syndromes (e. g. Apert syndrome) (Kreiborg 
& Cohen 1992).
FGF signalling is also essential for the progression of tooth 
development in mice (Celli et al. 1998). Also, studies using 
Fig. 2 Signalling carried out by 
growth factors, growth factor recep-
tors and transcription factors
Different growth factor-growth factor 
receptor combinations lead to activa-
tion/inactivation of a particular tran-
scription factor. Each transcription fac-
tor then drives or stops the expression 
of a particular set of genes including 
genes for structural proteins, proteins 
mediating cell migration, cell division 
or cell death. In many cases transcrip-
tion factors lead to expression of new 
growth factors by the cell for signalling 
to other cells, establishing a cell-to-cell 
“dialogue”.
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In mice where BMP activity was reduced by overexpression 
of the BMP antagonist Noggin, many aspects of tooth develop-
ment were affected. The mice lacked mandibular molars, the 
maxillary molars were reduced in size, had altered crown shape 
and reduced number of roots, while the incisors lacked enamel 
(Plikus et al. 2005).
These results indicate that BMP signalling controls impor-
tant and diverse cellular events during the different stages of 
tooth formation.
Oral clefts
The term oral cleft refers to the presence of a fissure or fissures 
in the lip and/or palate resulting in tissue discontinuity. It is 
one of the most common congenital orofacial defects with a 
reported incidence of one in 750 live births, which can be 
higher for certain racial groups such as those of Asian or native 
American ancestry (Croen et al. 1998).
Children with cleft lip and palate (CLP), can face problems 
during feeding, show speech and hearing difficulties, and to 
varying degrees suffer from disturbances in the normal facial 
and dental development (Hodgkinson et al. 2005). The im-
pact of the condition on the life of the individual and the need 
for high cost care by a team of several different professionals, 
including plastic or paediatric surgeons, maxillofacial sur-
geons, ENT specialists, speech pathologists, dentists and ortho-
dontists have triggered intense research into the genetic causes 
of this condition. Genetic information could lead to the de-
velopment of novel preventive and corrective therapies for 
CLP patients.
Cleft palate (CP) with or without cleft lip (CL) can occur 
isolated (70% of cases), or as part of developmental syndromes 
that are the result of chromosomal or teratogenic conditions 
(Stanier & Moore 2004). Multiple genes and environmental 
factors are implicated in the generation of CP/CLP. Knock-out 
mice with remarkable CLP phenotypes have helped to identify 
growth factors and transcription factors that are important for 
the development of the facial primordia. This growth contrib-
utes to the formation of the lip and palate, the approximation 
of these tissues and finally their fusion (Fig. 3).
Genetic abnormalities associated with oral clefts 
in humans
Defects of growth factors or their receptors have been shown 
to cause isolated (non-syndromic) or syndromic oral clefts in 
humans. Linkage and sequencing studies of families have 
identified mutations in the FGF8 and FGFR1 genes causing 
non-syndromic cleft lip and palate (Riley et al. 2007).
TGF3 has also been shown to be involved in oral cleft for-
mation in humans (Lidral et al. 1998).
We have found that in mice, conditional inactivation of a 
TGF receptor (TGFR2) in the neural crest cell population also 
causes cleft palate (Wurdak et al. 2005). The mutant embryos 
show facial asymmetry, micrognathia, smaller tongue and 
palatal shelves that are not elevated over the tongue (Fig. 4). 
These findings suggest that TGFR2 plays a very important 
role in orofacial development and further investigation is 
required to clarify its function in the normal development of 
the palate.
We have also recently found that inactivation of the growth 
factor BMP7, another member of the TGF family, causes de-
fects in tooth development and clefts in the soft and hard palate 
(Zouvelou et al. 2009) (Fig. 4).
The WNT signalling pathway
The WNT family of signalling molecules comprises 19 mem-
bers in humans. The WNT molecules act through specific re-
ceptors (Frizzled 1–10) to activate intracellular signals that 
dictate a variety of cell actions. 
During early craniofacial development in the mouse em-
bryo, members of the WNT family are expressed at tooth ini-
tiation sites of the oral epithelium, in the mesenchyme of the 
elevating palatal shelves, and at sites of future bone formation 
of the maxilla and mandible. WNT expression is often coinci-
dent with the expression of molecules of the Hedgehog and 
TGF- families (Silva Paiva et al. 2010).
Loss of WNT function in vertebrates causes a wide range of 
developmental defects.
Targeted inactivation of WNT signalling in mice causes re-
duced growth of the facial processes (Yamaguchi et al. 1999) 
or cleft lip with or without cleft palate (Juriloff et al. 2006). 
Reduction of WNT molecules in the mesenchyme during tooth 
initiation results in the formation of teeth with a reduced size 
(Sarkar & Sharpe 2000).
In humans, a mutation of the WNT3 gene has been linked 
to a rare condition called tetra-amelia (Niemann et al. 2004). 
Subjects with tetra-amelia lack all four limbs and often have a 
cleft lip with or without cleft palate.
The TGF signalling pathway
The Transforming Growth Factor beta (TGF) family of growth 
factors plays multiple and critical roles during all stages of 
tooth development. This family also includes the Bone Mor-
phogenetic Protein (BMP) and Activin signalling molecules.
Inactivation of a TGF receptor gene (TGFR2) in mouse 
neural crest cells resulted in cleft palate and abnormalities in 
the formation of the cranium (Ito et al. 2003, Wurdak et al. 
2005), thus implicating the TGF signalling pathway in the 
molecular cascade that dictates craniofacial development.
Inactivation of another TGF receptor (ALK5: Activin recep-
tor-Like Kinase 5) in mice causes unilateral or bilateral clefts 
of the upper lip (Li et al. 2008), indicating that the TGF 
pathway may be also important in lip formation.
Inactivation of the TGF3 gene in mice results in bilateral 
cleft of the secondary palate due to the non-fusion of the 
palatal shelf processes (Kaartinen et al. 1995, Kaartinen et al. 
1997). Half of the mutants exhibited severe clefting anteriorly 
that had as a consequence the exposure of the nasal cavity. 
Characteristically, none of the TGF3 mutants presented with 
any other craniofacial abnormality.
Mutations in TGF receptor genes (TGFR2 or TGFR3) were 
identified in members of ten families with an aortic aneurism-
type syndrome who also present with craniosynostosis, hyper-
telorism, bifid uvula and/or cleft palate (Loeys et al. 2005).
With respect to BMPs, several members of the BMP family 
have been shown to be expressed at various stages of tooth 
development.
BMP2 and BMP4 are expressed at particular times and in 
specific regions of the epithelium of the nasal and the maxil-
lary and mandibular processes (Francis-West et al. 1994). In 
experiments where Noggin, a molecule antagonizing the ac-
tion of BMP molecules, was applied on the facial processes of 
developing embryos, the shape and the size of the facial pro-
cesses were significantly altered (Wu et al. 2004). Overexpres-
sion or inhibition of BMP signalling in embryos caused cleft 
lip (Ashique et al. 2002).
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factor MSX1 causes lack of growth of the palatal shelves lead-
ing to the formation of a complete CP in mice (Satokata & 
Maas 1994).
CP with ankyloglossia is an X-linked inherited condition. 
Point mutations in the T-box transcription factor TBX22 are 
found in 8% of cleft palate patients (Braybrook et al. 2002). 
In addition to growth factors, transcription factors are im-
portant in the process of palatogenesis and lip formation.
In humans, a nonsense mutation in MSX1 was detected in 
subjects with CP/CL/CLP combinations (van de Boogaard et 
al. 2000) that represent approximately 2% of non-syndromic 
cleft cases (Jezewski et al. 2003). Absence of the transcription 
Fig. 3 Developmental process of formation of the palate
The four stages of secondary palate formation are:
1.  Growth of palatal shelves from the internal aspect of the maxillary processes
2.  Lowering of the tongue and horizontal elevation of the palatal shelves over the tongue
3.  Growth and approximation between the palatal shelves in the midline.
4.  Fusion of the palatal shelves and of the nasal septum to form a continuous secondary palate.
The signalling molecules and environmental factors (in bold) which play a role at each stage are shown.
Fig. 4 Developmental disturbances in the formation of the palate in mouse models
a. Wild type mouse embryo (head histological section, coronal view) with normal formation of the palate (indicated by the square).
b. Mouse embryo (head histological section, coronal view) not expressing a TGF receptor (TGFR2) at a particular developmental stage clearly demonstrates 
 defects in palatal formation with inability of the palatal shelves to elevate over the tongue and fuse (circled area).
c. Mouse embryo (head histological section, coronal view) not expressing the growth factor BMP7 at a particular developmental stage demonstrates defects in 
 palatal formation and lack of palatal shelf fusion (circled).
(Key: T, tongue; P, palate; PS, palatal shelf).
In humans, cleft of the palate is a relatively frequent clinical pathology.
Schweiz Monatsschr Zahnmed Vol. 121 7/8/2011 641
The genetic basis of craniofacial and dental abnormalities Research and Science
the surgeon frequently faces the problem of tissue shortage. 
Currently, intense research is under way for the isolation of 
suitable stem cells from amniotic fluid and adult tissues, in-
cluding the dental pulp, which could be potentially used to 
treat orofacial abnormalities (Pittenger et al. 1999, Gronthos 
et al. 2002, de Coppi et al. 2007, Bluteau et al. 2008). The 
possibility of isolating stem cells and “directing” them in the 
laboratory towards attaining specific fates (e. g. become bone 
cells, muscle cells, etc.) is exciting and promising. Such pro-
grammed cells can be seeded on suitably engineered scaffolds 
to regenerate an appropriate craniofacial tissue of the desired 
shape and dimensions (Alsberg et al. 2001, Mao et al. 2006, 
Panetta et al. 2008).
In addition, research on the mechanisms of scar-free wound 
repair in the embryo could together with tissue engineering 
achieve faultless results.
During the healing phase, after cleft palate closure, precursor 
stem cells and fibrocytes (blood-borne cells capable of entering 
wound sites) differentiate into myofibroblasts in response to 
growth factors and mechanical tension at the site of the wound 
(van Beurden et al. 2005). The contractile action of myofibro-
blasts in conjunction with a periosteal osteogenic reaction at 
the surgical repair site is thought to result in significant wound 
contraction and the formation of an immobile scar. This sub-
sequently leads to restricted maxillary growth and abnormali-
ties in tooth development and eruption (Wijdeveld et al. 1991).
The use of growth factors to inhibit the differentiation of 
fibroblasts into myofibroblasts, to hinder the action of myofi-
broblasts or to reduce their numbers by delivering apoptotic 
signals could potentially lead to modulation of palatal wound 
healing and reduction of scarring (van Beurden et al. 2005).
Mouse models are used in in vitro organ culture systems for 
the detailed investigation of the mechanisms of palatal forma-
tion. This technique (Fig. 5; T. Kouskoura, preliminary results) 
allows the detailed study of the processes involved in the de-
velopment of the palate (proliferation, apoptosis, fusion, etc.) 
and the effect of growth factors or chemicals on palate forma-
tion in a well controlled environment. This greatly aids our 
understanding of the specific aetiology of the cleft phenotype 
TBX22 is expressed in the developing palatal shelves and base 
of the tongue. A short frenulum may be responsible for the 
restricted tongue movement and may prevent full elevation of 
the palatal shelves.
IRF6 is another transcription factor involved in non-syn-
dromic cases of CL/CLP. IRF6 is also involved in the Van der 
Woude syndrome where CL and/or CP occur with the addi-
tional feature of pits in the lower lip (Kondo et al. 2002). IRF6 
is considered as a major gene causing approximately 12% of 
CL or CLP phenotypes (Zucchero et al. 2004).
Clinical relevance of genetic findings
Currently, craniofacial abnormalities such as oral clefts, holo-
prosenchephaly and craniosynostosis can be detected by mod-
ern ultrasound examination as early as at 16 weeks of gestation 
(Ghi et al. 2002). In oral clefts, which are particularly relevant 
to clinical dentistry, the only therapy available for the closure 
of the cleft(s) is surgical intervention. However, cleft repair 
rarely produces ideal facial aesthetics (Nollet et al. 2007), 
while the growth of the upper face is often deficient (Nollet 
et al. 2008).
Identification of the molecular players and unravelling of 
the genetic pathways that dictate palatogenesis and lip forma-
tion could offer new and exciting possibilities for the preven-
tion and therapy of CLP.
Knowledge of the genetic mutations that cause inherited 
CLP allows the genetic examination and counselling of future 
parents with traits of oral cleft in the family.
Stem cell therapy is another future possibility of correcting 
CLP before birth. During the formation of orofacial structures 
(5 to 12 weeks of pregnancy) the immature immune system of 
the foetus allows the introduction of stem cells free of the 
genetic abnormality. The transplantation and engraftment of 
suitable stem cells could in principle result in the correction 
of the malformation (Jones & Trainor 2004).
Stem cell technology combined with tissue engineering could 
also provide solutions for improvements in the treatment of 
oral clefts in children. When surgically correcting oral clefts, 
Fig. 5 In vitro organ culture system of developing mouse palates
Developing palatal shelves are collected from mouse embryos at appropriate stages and are 
cultured in vitro. This system allows us to study the process of palate formation in detail and to 
directly assess the function of growth factors/growth factor inhibitors.
Microdissected palatal shelves are positioned with their midline aspects (fusing surface) apposed 
and their oral surface facing up, on filters supported by a metal grid (a). The grid (grid size: 
0.65 mm) is placed in a culture chamber filled with fluid medium up to the grid surface. This is 
taken as time point 0 h (0 hours). 
After 72 h of culture the palatal shelves have fused (b) and after more prolonged culture the 
 expected morphology of a fully formed secondary palate is obvious (c: 168 h; d: 240 h).
The appearance of palatal rugae (circled area), a landmark of the oral epithelium of the palate, 
was observed in many cases at 240 h of culture (e).
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the enamel, dentine, dental pulp and periodontium (Mitsiadis 
& Graf 2009).
A schematic representation of these processes and the already 
known growth factors and transcription factors involved in 
odontogenesis is shown in Figure 6.
Genes associated with tooth agenesis in humans
Oligodontia and microdontia (small teeth) are common dental 
features within subjects affected by ectodermal dysplasia syn-
dromes. In the EEC (Ectrodactyly, Ectodermal dysplasia, Cleft-
ing) type of ectodermal dysplasia an additional feature can be 
the presence of CL and CP.
Genetic analyses indicated that the transcription factor p63 
is responsible for this type of ectodermal dysplasia in humans. 
p63 is important for the correct FGF and BMP signalling during 
early stages of tooth formation (Celli et al. 1999).
 Inactivation of p63 in mice leads to arrest of tooth develop-
ment at early stages (Mills et al. 1999).
Subjects with X-linked hypohidrotic ectodermal dysplasia 
exhibit oligodontia, and a candidate gene was cloned after po-
sitional gene analysis in humans (Kere et al. 1996).
The mouse homologue of this gene (Tabby) (Ferguson et al. 
1997) encodes for a signalling molecule (called EDA). Knock-
out Tabby mice present similar phenotype to that of EED pa-
tients (Mikkola & Thesleff 2003). Injection of the missing EDA 
protein to pregnant Tabby mice permanently corrected the 
dysplasia (Gaide & Schneider 2003).
The Rieger syndrome is characterised by severe oligodontia 
in association with midfacial hypoplasia (Childers & Wright 
1986). The transcription factor PITX2 is the responsible gene 
for the Rieger syndrome in humans. PITX2 knock-out mice 
and also provides an excellent model to test novel cell- or drug-
based therapies.
Tooth agenesis in humans
Tooth agenesis refers to failure of tooth development. In hu-
mans, tooth agenesis may involve one or more teeth (or classes 
of teeth). Failure of development of the third molars is the 
most common agenesis (10–25%). Patients congenitally lack-
ing less than six teeth (excluding the frequently missing third 
molars) suffer from hypodontia, while if six or more teeth are 
missing the condition is termed oligodontia. About 80% of 
hypodontia patients lack only one to two teeth; approximately 
1% of the general population suffers from oligodontia (Lidral 
& Reising 2002).
Usually, the permanent teeth are congenitally missing, while 
the lack of primary teeth is relatively rare (0.5–0.9%) and as-
sociated with lack of the permanent successor teeth (Vastardis 
2000). In most cases, oligodontia is linked to genetic disorders 
(Vastardis, 2000). Lack of teeth can be an isolated abnormal-
ity or part of a syndrome (such as Rieger syndrome, Witkop 
syndrome and Ectodermal Dysplasia).
Tooth formation is another example of the crucial role of 
growth factors and transcription factors during embryonic 
development. At six weeks of gestation a series of molecular 
events takes place in the forming oral cavity. Cells of the epi-
thelial layer interact with cells of the underlying mesenchyme. 
Growth factors and transcription factors provide the “molecu-
lar language” for this tissue-tissue communication. In this man-
ner, cells of the two tissues instruct each other about the place 
and the form of the teeth. Thereafter, subgroups of these cells 
migrate, proliferate and differentiate into cell types forming 
Fig. 6 Process of odontogenesis (tooth formation)
The basis of tooth development is a constant communication between cells of the epithelium and cells of the underlying neural crest derived mesenchyme. This 
is carried out by means of signalling molecules, which activate (or inactivate) transcription factors. This leads to expression of different groups of gene each time. 
The same principle is found in the formation of other structures of the head, including formation of the palate.
The molecules known to be involved at each stage of the process of odontogenesis are shown, with those involved in human tooth malformation shown 
in bold.
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and hypodontia could provide strategies for therapies in the 
future.
Résumé
Le développement embryonnaire de la tête, qui inclut la for-
mation des structures dentaires, correspond à un processus 
complexe et délicat guidé par des programmes génétiques spé-
cifiques. Les changements génétiques et les facteurs environ-
nementaux peuvent perturber l’exécution de ces programmes 
et aboutir à des anomalies des structures oro-faciales et den-
taires. Les fentes oro-faciales ainsi que l’hypodontie et l’oligo-
dontie sont des exemples d’anomalies fréquemment observées 
en clinique dentaire. Un approfondissement des mécanismes 
et des gènes impliqués dans la formation des structures oro-
faciales et dentaires a été progressivement obtenu par l’analyse 
génétique de familles et par l’utilisation de modèles expéri-
mentaux de vertébrés tels que la souris et le poulet.
Les fentes oro-faciales, en particulier la fente labiale accom-
pagnée ou non d’une fente du palais ainsi que les fentes pala-
tines seules, se développent à cause de l’expression inappro-
priée ou défectueuse de protéines, et également à cause de leur 
absence. Quand cela se produit, les tissus embryonnaires qui 
contribuent à la formation des lèvres ou du palais ne se déve-
loppent pas, ne se rapprochent pas les uns des autres et ne 
fusionnent pas, ce qui entraîne la formation d’une fente/fis-
sure. Dans les cas de fentes humaines, des défauts de certaines 
protéines (telles que MSX1, TBX22 et IRF6) ont été confirmés 
par analyse génétique. Lorsque des modèles de souris ne pos-
sédant plus ces protéines ont été créés et analysés, il a été mis 
en évidence la présence de fentes similaires chez ces animaux. 
En particulier, l’absence de MSX1 chez la souris affecte la crois-
sance des processus palatins, l’absence de TBX22 empêche 
l’abaissement de la langue et l’élévation des processus palatins, 
alors que l’absence de IRF6 affecte la fusion de ces mêmes pro-
cessus palatins.
Le développement des dents correspond à un autre processus 
qui peut être fortement affecté par des défauts des gènes co-
dants pour des protéines-clés. Chez l’homme, l’absence de dents 
peut survenir comme une anomalie isolée ou peut être l’une 
des diverses anomalies observées dans des syndromes tels le 
syndrome de Rieger, le syndrome Witkop ou la dysplasie ecto-
dermique. Chez l’homme, le syndrome de Rieger est caractérisé 
par une oligodontie sévère et une hypoplasie de la face moyenne, 
et est causé par des défauts du gène codant pour la protéine 
PITX2. Les souris knock-out, qui n’expriment plus PITX2, 
montrent des anomalies du développement du maxillaire et 
de la mandibule, ainsi qu’une agénésie dentaire. Des défauts 
du gène MSX1 engendrent le syndrome de Witkop (caractérisé 
par des dents manquantes, coniques ou petites et des ongles 
altérés), alors que MSX1 est également impliqué dans des cas 
isolés (non liés à un syndrome) d’absence de dents chez 
l’homme. Les modèles de souris qui n’expriment plus MSX1 
montrent des anomalies des os du visage ainsi qu’une agénésie 
dentaire. Chez l’homme, l’oligodontie et la microdontie appa-
raissent aussi comme une caractéristique de la dysplasie ecto-
dermique. Les analyses génétiques montrent que le gène p63 
est lié à la dysplasie ectodermique de type EEC (ectrodactylie, 
dysplasie ectodermique, fentes). Lorsque le même gène a été 
inactivé chez la souris, le développement dentaire s’est vu ar-
rêté de façon précoce, entraînant une agénésie dentaire.
Le développement de nouvelles thérapies cliniques pour les 
pathologies oro-faciales et dentaires dépend fortement de la 
connaissance détaillée des processus moléculaires et cellulaires 
exhibit a phenotype with abnormal development of the max-
illa and mandible, cleft palate, and absence of teeth (Lu et al. 
1999).
The transcription factors MSX1 and PAX9 are responsible for 
partial tooth agenesis in humans. MSX1 is induced by BMP 
and FGF molecules and its mutation leads to selective absence 
of upper lateral incisors and/or upper and lower second pre-
molar teeth (Vastardis et al. 1996, Stockton et al. 2000, Lidral 
& Reising 2002). MSX1 mutations were also detected in non-
isolated tooth agenesis, where hypodontia outside the area of 
the cleft occurs in association with CLP (van den Boogaard et 
al. 2000). MSX1 mutation is also involved in a syndromic form 
(Witkop syndrome) affecting both teeth and nails (Jumlongras 
et al. 2001).
In mice, deletion of the MSX1 gene results in CP, abnor-
malities in facial bones and tooth agenesis (Satokata & Maas 
1994). PAX9 is induced by FGF molecules and its mutation 
leads to agenesis of molar teeth (Nieminen et al. 2001, Frazier-
Bowers et al. 2002, Das et al. 2003).
Mice deficient for PAX9 present a phenotype which is simi-
lar to that observed in MSX1 knock-out mice (Peters et al. 
1998).
Clinical relevance of the genetic findings
Identification of the genes responsible for syndromes linked 
to oligodontia will help prenatal diagnosis and genetic coun-
selling. For example, a successful early (11 weeks of gestation) 
DNA-based prenatal diagnosis has been applied in a family 
suffering from the EEC type of ectodermal dysplasia (South et 
al. 2002).
The gradual identification of the genes responsible for tooth 
formation could also find remarkable applications in clinical 
dentistry.
The treatment options available for patients congenitally 
lacking teeth or for patients who lose their teeth later in life 
include different types of artificial prostheses. However, the 
ideal form of tooth replacement is with a biological structure 
closely resembling the missing tooth. It is hoped that the 
knowledge on the molecules that drive tooth development and 
the advances in stem cell research will allow the engineering 
of new teeth suitable for clinical application. The transition 
from the laboratory to clinical trials is much easier in dentistry 
than in medicine where more vital organs are making this 
exercise too risky.
In fact, recent research has shown that a mouse tooth germ 
grown in vitro from combined embryonic epithelial and mes-
enchymal tooth cells developed into a fully functional tooth, 
which subsequently erupted and came into occlusion (Ikeda 
et al. 2009). This is a significant development and shows that 
as our knowledge on the genetic programs responsible for 
tooth formation increases, the possibility of directing stem 
cells towards forming an entire functional organ by mimicking 
embryonic developmental processes may become a reality in 
the near future (Ohazama et al. 2004).
Conclusions
The development of novel clinical therapies for orofacial ab-
normalities, such as clefts and tooth agenesis, depends very 
much on a detailed knowledge of the genetic processes in-
volved in the formation of orofacial structures. Intense research 
in the field of developmental biology aims to lead to clinical 
benefits. Laboratory development of new products for clefts 
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impliqués dans la formation de la tête. Des efforts sont faits 
pour développer des technologies basées sur des protéines im-
portantes pour la signalisation cellulaire et l’expression de gènes. 
Ces protéines pourraient être utilisées pour moduler le com-
portement cellulaire et réduire la cicatrisation après la répara-
tion chirurgicale des fentes, ou bien être appliquées dans des 
techniques d’ingénierie tissulaire ayant pour but de développer 
des tissus oro-faciaux et même des organes, comme les dents, 
pour une utilisation en transplantation.
Zusammenfassung
Die embryonale Kopfentwicklung, einschliesslich der Bildung 
von dentalen Strukturen, ist ein komplexer und schwieriger 
Prozess, der durch spezifische genetische Programme geführt 
ist. Genetische Veränderungen und Umweltfaktoren können 
die Ausführung dieser Programme stören und führen zu Ano-
malien in orofazialen und dentalen Strukturen. Orofaziale 
Spalten und Hypodontie/Oligodontie sind Beispiele für solche 
Auffälligkeiten, die häufig in Zahnkliniken gesehen werden.
Das Verständnis für die Mechanismen und Gene, welche bei 
der Bildung der orofazialen und dentalen Strukturen eingebun-
den sind, wurde schrittweise durch die genetische Analyse von 
Familien und die Verwendung von experimentellen Tiermo-
dellen, wie Maus und Küken, gewonnen.
Orale Spalten, die Lippenspalten mit oder ohne Gaumen-
spalte oder alleinige Gaumenspalten umfassen, können durch 
falsch exprimierte, defekte oder fehlende Schlüsseleiweisse ver-
ursacht werden. Eine Spalte entsteht, wenn Wachstum, Annä-
herung oder Fusion der zur Lippen- oder Gaumenbildung bei- 
tragenden embryonalen Gewebe ausbleibt. Mittels genetischer 
Analyse konnten beim Menschen Veränderungen in einigen 
solchen Schlüsseleiweissen (z. B. MSX1, TBX22 und IRF6) nach-
gewiesen werden. Als Mausmodelle, in denen diese Eiweisse 
fehlen, generiert und analysiert wurden, sah man, dass orale 
Spalten auch in der Maus auftreten. Präzise gesagt beinträchtigt 
das Fehlen von MSX1 das Wachstum der Gaumenlappen, das 
Fehlen von TBX22 das Absenken der Zunge und die Anhebung 
der Gaumenlappen, während das Fehlen von IRF6 den Fusions-
prozess der Gaumenlappen selbst betrifft.
Auch die Zahnentwicklung ist ein Prozess, der durch das 
Fehlen bestimmter Schlüsseleiweisse stark beeinträchtigt wer-
den kann. Beim Menschen können fehlende Zähne als isolier-
tes Ereignis auftreten oder aber Bestandteil der pathologischen 
Veränderungen sein, die im Rahmen eines Syndromes auftre-
ten, wie z. B. des Rieger-Syndroms, des Witkop-Syndroms oder 
der ektodermalen Dysplasie. Das Rieger-Syndrom ist durch 
schwere Oligodontie und Mittelgesichtshypoplasie charakte-
risiert und wird durch Defekte in PITX2 verursacht. Knock-out-
Mäuse, denen das PITX2 fehlt, zeigen abnormale Entwicklung 
des Ober- und Unterkiefers sowie Zahnagenese. Defekte in MSX1 
liegen dem Witkop-Syndrom zugrunde, welches durch feh-
lende, konische oder kleine Zähne sowie beinträchtigte Nagel-
bildung charakterisiert ist. MSX1 kann aber auch in isolierten, 
nicht syndromischen Fällen von fehlenden Zähnen involviert 
sein. Mäuse, in denen MSX1 entfernt wurde, zeigen abnormale 
Gesichtsknochenbildung und Zahnagenese. Beim Menschen 
können Oligodontie und Mikrodontie auch als Bestandteil der 
ektodermalen Dysplasie auftreten. Genetische Analysen haben 
ergeben, dass das p63-Gen mit einem Subtyp der ektodermalen 
Dysplasie, dem EEC-Syndrom (Ektrodaktylie, ektodermale Dys-
plasie, Lippen-Kiefer-Gaumen-Spalte), verbunden ist. Inaktivie-
rung dieses Genes in der Maus verursacht einen frühen Stopp 
in der Zahnentwicklung und dadurch Zahnagenese.
Die Entwicklung neuartiger Therapien für klinische orofazi-
ale und zahnärztliche pathologische Anomalien hängt sehr 
stark von einer detaillierten Kenntnis der molekularen und 
zellulären Prozesse der embryonalen Kopfbildung ab.
Anstrengungen sind im Gange, neue Technologien zu ent-
wicklen, die auf solchen für Signaltransduktion und Genregu-
lierung wichtigen Eiweissen basieren. Diese Eiweisse könnten 
dazu verwendet werden, das Verhalten von Zellen zu beein-
flussen und Narbenbildung nach operativem Eingriff an einer 
Spalte zu reduzieren. Diese Eiweisse könnten aber auch für so-
genanntes Gewebe-Engineering verwendet werden, mit dem 
Ziel kraniofaziale Gewebe oder Organe wie Zähne herzustellen 
und für Transplantationen zu verwenden.
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